High glucose induces HGF-independent activation of Met receptor in human renal tubular epithelium

J Recept Signal Transduct Res. 2017 Dec;37(6):535-542. doi: 10.1080/10799893.2017.1365902. Epub 2017 Aug 18.

Abstract

Context: The role of hepatocyte growth factor (HGF) in diabetic kidney damage remains controversial.

Objective: To test the hypothesis that high glucose levels activate pathways related to HGF and its receptor Met and that this could participate in glucose-induced renal cell damage.

Materials and methods: HK2 cells, a human proximal tubule epithelial cell line, were stimulated with high glucose for 48 hours. Levels of pMet/Met, pEGFR/EGFR, pSTAT3/STAT3, pAkt/Akt and pERK1/2/ERK1/2 were studied by immunoblotting. Absence of HGF was verified by qRT-PCR and ELISA.

Results: High glucose level activated Met and its downstream pathways STAT3, Akt and ERK independently of HGF. High glucose induced an integrin ligand fibronectin. HGF-independent Met phosphorylation was prevented by inhibition of integrin α5β1, Met inhibitor crizotinib, Src inhibitors PP2 and SU5565, but not by EGFR inhibitor AG1478. High glucose increased the expression of TGFβ-1, CTGF and the tubular damage marker KIM-1 and increased apoptosis of HK2 cells, effects inhibited by crizotinib.

Conclusion: High glucose activated Met receptor in HK2 cells independently of HGF, via induction of integrin α5β1 and downstream signaling. This mode of Met activation was associated with tubular cell damage and apoptosis and it may represent a novel pathogenic mechanism and a treatment target in diabetic nephropathy.

Keywords: Diabetic nephropathy; HGF; fibronectin; high glucose level; integrin α5β1; met receptor.

MeSH terms

  • Apoptosis / drug effects
  • Cell Line
  • Diabetic Nephropathies / genetics*
  • Diabetic Nephropathies / metabolism
  • Diabetic Nephropathies / pathology
  • Extracellular Signal-Regulated MAP Kinases / genetics
  • Gene Expression Regulation / drug effects
  • Glucose / genetics
  • Glucose / pharmacology
  • Glucose / toxicity
  • Hepatocyte Growth Factor / genetics*
  • Hepatocyte Growth Factor / metabolism
  • Humans
  • Integrin alpha5beta1 / genetics
  • Kidney / drug effects
  • Kidney / metabolism
  • Kidney / pathology
  • Kidney Tubules, Proximal / drug effects
  • Kidney Tubules, Proximal / metabolism*
  • Kidney Tubules, Proximal / pathology
  • Oncogene Protein v-akt / genetics
  • Phosphorylation / drug effects
  • Proto-Oncogene Proteins c-met / genetics*
  • STAT3 Transcription Factor / genetics
  • Signal Transduction / drug effects

Substances

  • HGF protein, human
  • Integrin alpha5beta1
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Hepatocyte Growth Factor
  • MET protein, human
  • Proto-Oncogene Proteins c-met
  • Oncogene Protein v-akt
  • Extracellular Signal-Regulated MAP Kinases
  • Glucose